Cochrane Abstracts
Rosiglitazone for type 2 diabetes mellitus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rosiglitazone for Type 2 Diabetes Mellitus." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Rosiglitazone_for_type_2_diabetes_mellitus_Edited__no_change_to_conclusions_. Accessed 04 December 2023.
Rosiglitazone for type 2 diabetes mellitus. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Rosiglitazone_for_type_2_diabetes_mellitus_Edited__no_change_to_conclusions_. Accessed December 4, 2023.
Rosiglitazone for type 2 diabetes mellitus. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Rosiglitazone_for_type_2_diabetes_mellitus_Edited__no_change_to_conclusions_
Rosiglitazone for Type 2 Diabetes Mellitus [Internet]. In: Cochrane Abstracts. [cited 2023 December 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Rosiglitazone_for_type_2_diabetes_mellitus_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rosiglitazone for type 2 diabetes mellitus
ID - 434693
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Rosiglitazone_for_type_2_diabetes_mellitus_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
